Lv11
40 积分 2025-10-13 加入
Preclinical and First-in-Human Study of Carbonic Anhydrase IX-Targeting Theranostic Pair, [68Ga]Ga/[177Lu]Lu-NYM096, in Clear Cell Renal Cell Carcinoma
3小时前
已完结
The Preclinical Pharmacology of Tepotinib—A Highly Selective MET Inhibitor with Activity in Tumors Harboring MET Alterations
3个月前
已完结
Properties of FDA-approved small molecule protein kinase inhibitors: A 2021 update
3个月前
已完结
Capmatinib Could Alter NSCLC Treatment Landscape
3个月前
已关闭
Evolving roles of MET as a therapeutic target in NSCLC and beyond
3个月前
已完结
皖公网安备34019202002308
